other hand, there was no documentation of any requirement to respond to the patients' wishes and the staff themselves appeared to have an extremely authoritative position. Most surprising of all, the only route of communication of anything other than demographic details mentioned for the patients was by means of a formal complaint to the Trust authorities. This was all in spite of the fact that at least some of these leaflets had been approved by the central Trust information committee.
Ian Forgacs (December 2006 JRSM 1 ) confessed to being trapped by the conflict of interest generated by his moral allegiance towards the principles of the NHS and his ethical concerns regarding best practice for a particular patient. This was solved in that case by seeing the patient privately. We must assume that the personal financial gain did not enter into the equation. However, this solution can only be seen as a positive gain for the NHS if the patient can afford to pay. Dr Forgacs' ability to facilitate rapid resolution for a private patient's medical problem was because he was in control of the management process. The NHS situation could be improved if doctors were given the opportunity to exploit similar management pathways.
My approach was to develop my own outpatient IT system, so that from the receipt of the general practitioner communication the patient could be seen on any of the four weekdays on which I had a clinic. Clearly, I decided the degree of urgency but, when appropriate, I could see the patient on the next day. Any complex imaging process that might be necessary unfortunately fell into the NHS resource-driven black hole, because management refuses to run a theatre or scanner outside of 'normal working hours' unless the patient can stump up the associated fee.
My system met with managerial obstruction and resentment: patients loved it. Letters were only dictated on new referrals. The remaining correspondence was IT generated. The reduction in secretarial time was rewarded by reducing my access to secretarial help to 2½ days per week without the budget savings being returned to my speciality. (The penalty I paid for rocking the boat.) It is the numerous conflicts of interest within health-care provision which fuels the demand for and the acceptance of private practice.
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Mark Aitken
Colchester General Hospital, Colchester CO4 5JL, UK E-mail: mark.aitken@essexrivers.nhs.uk I was delighted to see an article in the JRSM on homeopathy, 1 but my pleasure soon turned to dismay when the terms 'quackery' and 'quacks' appeared no less than eight times on the first page. No prejudice or bias here then! The author's hostility and frustration could be clearly felt through the rambling and bitter prose. It is a puzzle why a proportion of one's colleagues become so very angry when the subject of complementary medicine is raised. Practitioners of complementary medicine, including homeopathy, are among the mildest mannered and most well meaning of individuals, who have only their patients' best interests at heart.
The idea that a doctor would go into homeopathy 'for the money' is ludicrous-there's precious little of that in it. What draws so many of our colleagues and their patients is disenchantment with the harshness and side effects of modern therapeutics. Homeopathy and other gentle complementary therapies are both effective and free of those side effects that so plague conventional medicine, with its mechanistic approach to human illness. Since we are all part of a caring profession, why should such an approach be so distressing to so many in the medical establishment?
The wiser heads among us realise that all forms of therapeutics have their place and that we should be grateful for the diversity of approach that so adds to the interest of the medical world. Homeopathy copes well with those awkward illnesses (e.g. skin conditions, depression and asthma) for which conventional medicine has few answers, and vice versa. More tolerance and understanding would be a good thing.
Competing interests DH is a Licensed Associate of the Faculty of Homeopathy and is able to practice homeopathy in relation to dentistry. 
Gender bias in research
Holdcroft 1 writes about the very real shortage of clinical trials data from studies in women. While this is true in a number of disease areas; it is not true of studies in hormone replacement and related fields, for example. The exclusion of women from clinical research studies was the direct result of the Thalidomide disaster, which led to the setting up of the Dunlop Committee, forerunner to the Medicine's Control Agency. It was for many years considered to be unethical to include women in clinical trials who were known to be, or who might possibly have been, pregnant. This effectively excluded females from between 12 and 55 years of age. There was no intent to deny women the benefits of medical advances and any suggestion that this situation accorded a lower status to women is misconceived.
It is true that the difference between the sexes has been neglected in research at all levels, 2 something that requires much greater emphasis and more investigation in the future. I would like to add a personal anecdote to Scadding's article 1 on bacillary dysentery in Egypt. In March 1944 I was admitted to hospital in Bangalore, India, with mild bacillary dysentery. My treatment consisted of repeated doses of a mixture of magnesium and sodium sulphate, the standard treatment at that time. It seemed to me that this purgation was perpetuating my original symptoms and that this might go on indefinitely. I therefore hatched a plot with the Italian orderly (Italian prisoners of war were employed as orderlies in hospitals in India) to chart my treatment but not to give it to me. The result was impressive; within 48 hours I was 'formed', and was discharged.
Scadding referred briefly to 'Some probably harmful procedures were still sometimes advocated; for instance there was even the residue of the idea that saline purgation ought to be helpful in ridding the bowel of the infective agent.' Exactly when sulphaguanide became available in India and South East Asia is not clear, but it was certainly in use in Singapore in September 1945. Stitt's Diagnosis, Prevention and Treatment of Tropical Diseases, 2 published in 1943, clarifies the situation; after quoting a number of
